Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach (PROTECT)
Sponsor: RECORDATI GROUP
A observational or N/A phase clinical study on Methylmalonic Acidemia and Propionic Acidemia, this trial is actively recruiting participants. The trial is conducted by RECORDATI GROUP and has accumulated 12 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Dec 2025 — Present [monthly]
Recruiting
-
Sep 2025 — Dec 2025 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Dec 2023 — Mar 2024 [monthly]
Recruiting
-
Apr 2023 — Dec 2023 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2022 — Apr 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
First recorded
Jan 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- RECORDATI GROUP
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barcelona, Spain , Bilbao, Spain , Bordeaux, France , Bremen, Germany , Florence, Italy , London, United Kingdom , Madrid, Spain , Marseille, France , Milan, Italy , Monza, Italy and 14 more locations